Companies OptimizeRx
OptimizeRx (OPRX): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me OptimizeRx’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $970,357FY2023
- $973,132FY2024
- $2,717,717FY2025
CEO total pay was $2,717,717 in fiscal 2025, up from $973,132 in fiscal 2024.
FY2025: salary $500,000 · bonus $0 · stock awards $752,184 · option awards $834,310
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Stephen Silvestro | $500,000 | $0 | $752,184 | $834,310 | $627,623 | $0 | $3,600 | $2,717,717 |
| Chief Executive Officer | ||||||||
| Theresa Greco | 367,500 | 0 | 353,182 | 409,312 | 398,471 | 0 | 15,800 | 1,544,265 |
| Chief Commercial Officer | ||||||||
| Edward Stelmakh | 450,000 | 0 | 252,188 | 334,309 | 471,873 | 0 | 15,800 | 1,524,170 |
| Chief Financial & Strategy Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Stephen Silvestro | $2,717,717 | $973,132 | $970,357 | ↑ +1,744,585 |
| Theresa Greco | 1,544,265 | — | — | — |
| Edward Stelmakh | 1,524,170 | 1,009,304 | 929,726 | ↑ +514,866 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
| CEO STI target (% of salary) | 80% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Reserve Proposal | OTHER | 2026-04-10 | — | — | — | — | $18,765,075 |
Vehicle mix — grant-date fair value by award type
Grant-level vehicle detail not disclosed.
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Theresa Greco | RSU | 2,441 | — | $29,927 |
| Edward Stelmakh | RSU | 5,237 | — | 64,206 |
| Edward Stelmakh | Option | 5,237 | 12.73 | — |
| Theresa Greco | RSU | 6,173 | — | 75,681 |
| Stephen Silvestro | RSU | 6,547 | — | 80,266 |
| Stephen Silvestro | Option | 6,547 | 12.73 | — |
| Theresa Greco | RSU | 7,042 | — | 86,335 |
| Theresa Greco | RSU | 10,352 | — | 126,916 |
| Theresa Greco | Option | 11,920 | 8.1 | — |
| Theresa Greco | Option | 12,133 | 10.65 | — |
| Stephen Silvestro | RSU | 15,625 | — | 191,563 |
| Edward Stelmakh | RSU | 15,625 | — | 191,563 |
| Theresa Greco | RSU | 15,625 | — | 191,563 |
| Theresa Greco | Option | 19,436 | 4.83 | — |
| Stephen Silvestro | RSU | 27,606 | — | 338,450 |
| Edward Stelmakh | RSU | 27,606 | — | 338,450 |
| Stephen Silvestro | Option | 35,156 | 16.14 | — |
| Edward Stelmakh | Option | 35,156 | 16.14 | — |
| Theresa Greco | Option | 35,156 | 16.14 | — |
| Stephen Silvestro | RSU | 46,948 | — | 575,582 |
| Stephen Silvestro | Option | 51,828 | 4.83 | — |
| Edward Stelmakh | Option | 51,828 | 4.83 | — |
| Stephen Silvestro | Option | 80,884 | 10.65 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Lynn O'Connor VosIndependent · Strategic · Audit · Nominating/Governance · Compensation | $119,000 | $149,994 | — | — | — | $268,994 |
| Patrick SpanglerIndependent · Strategic · Audit (Chair) · Compensation | 85,000 | 149,994 | — | — | — | 234,994 |
| Catherine KlemaIndependent · Strategic · Audit · Nominating/Governance (Chair) | 78,000 | 149,994 | — | — | — | 227,994 |
| James LangIndependent · Nominating/Governance · Compensation (Chair) | 54,000 | 149,994 | — | — | — | 203,994 |
| Gregory WassonIndependent · Strategic · Compensation | 51,000 | 149,994 | — | — | — | 200,994 |
| Stephen SilvestroEmployee director · Partial-year service | — | — | — | — | — | 0 |
| Mariyamma Varghese PrestiIndependent · Audit · Partial-year service · Newly elected | — | — | — | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $150,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 10,000 / 8,000 |
| Stock ownership guideline | $120,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $387,000 |
| Equity awards (grant-date value) | $749,968 |
| All other compensation | $0 |
| Total cost of the board | $1,136,968 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names OptimizeRx as a peer
Companies that benchmark against OPRX
3 companies name OPRX as a compensation peer
The list of companies that name OPRX as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Viant Technology Inc. | 2025 | Mark Morelli | $1,140,809 | $6,206,906 | $0 | $2,079,576 | $9,634,679 |
| 2 | Domo, Inc. | 2026 | Joshua James | 500,000 | 8,357,004 | 0 | 593,550 | 9,465,244 |
| 3 | Phreesia, Inc. | 2026 | Chaim Indig | 515,000 | 7,562,706 | 0 | 0 | 8,077,706 |
| 4 | Kaltura, Inc. | 2025 | Ron Yekutiel | 552,985 | 5,431,579 | 0 | 353,471 | 6,412,754 |
| 5 | SoundThinking, Inc. | 2025 | Ralph Clark | 472,500 | 3,818,151 | 0 | 302,400 | 4,600,051 |
| 6 | American Well Corporation | 2025 | Ido Schoenberg | 701,755 | 1,294,331 | 0 | 2,010,100 | 4,162,171 |
| 7 | Health Catalyst, Inc. | 2025 | Daniel Burton | 525,000 | 3,444,040 | 0 | 0 | 3,991,159 |
| 8 | OptimizeRx | 2025 | Stephen Silvestro | 500,000 | 752,184 | 834,310 | 627,623 | 2,717,717 |
| 9 | Augmedix, Inc. | 2022 | Emmanuel Krakaris | 450,000 | 0 | 423,150 | 280,000 | 1,157,484 |
| 10 | Simulations Plus, Inc. | 2025 | Shawn O'Connor | 524,725 | 0 | 567,450 | 0 | 1,096,572 |
| 11 | CoreCard Corporation | 2024 | J. Leland Strange | 500,000 | 152,688 | 0 | 0 | 906,669 |
| 12 | HealthStream, Inc. | 2025 | Robert Frist | 400,500 | 224,977 | 79,550 | 158,100 | 868,037 |
| 13 | iCAD, Inc. | 2023 | Dana Brown | 315,385 | 0 | 521,093 | 0 | 849,047 |
| — | CareCloud, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Arteris, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Intellicheck, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Smith Micro Software, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| OptimizeRx | 191% | not disclosed | not disclosed | Pearl Meyer |
| American Well Corporation | not disclosed | PSU 45 · Cash LTI 45 · RSU 10 | No | Aon |
| Arteris, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Augmedix, Inc. | not disclosed | Options 100 | not disclosed | Compensia, Inc. |
| CareCloud, Inc. | not disclosed | RSUs 100 | not disclosed | not disclosed |
| CoreCard Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Domo, Inc. | 119% | RSU 100 | No | Compensia |
| Health Catalyst, Inc. | 39% | RSU 50 · PRSU 50 | Yes — TSR Achievement | Aon |
| HealthStream, Inc. | 97.6% | not disclosed | No | not disclosed |
| iCAD, Inc. | not disclosed | Option 100 | not disclosed | not disclosed |
| Intellicheck, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Kaltura, Inc. | 68% | RSU 100 | not disclosed | FW Cook |
| Phreesia, Inc. | 140.3% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook, Inc. |
| Simulations Plus, Inc. | not disclosed | Options 100 | not disclosed | Pearl Meyer |
| Smith Micro Software, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| SoundThinking, Inc. | not disclosed | RSU 50 · PSU 50 | No | Aon |
| Viant Technology Inc. | 121% | PSU 60 · RSU 40 | No | Pearl Meyer |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-09 | 11,660,549 | 895,095 | 98,152 | 92.87% | Passed |
| 2025 | 2025-06-11 | 5,443,720 | 3,857,653 | 3,757,636 | 58.53% | Passed |
| 2024 | 2024-06-05 | 8,790,190 | 4,676,450 | 97,026 | 65.27% | Passed |
| 2023 | 2023-06-07 | 4,722,546 | 6,738,014 | 393,696 | 41.21% | Failed |
| 2022 | 2022-06-09 | 8,907,079 | 4,678,794 | 423,393 | 65.56% | Passed |
| 2021 | 2021-08-19 | 9,935,017 | 877,491 | 629,640 | 91.88% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-09 | 92.87%a |
| 2025 | 2025-06-11 | 58.53%b |
| 2024 | 2024-06-05 | 65.27%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “PROPOSAL ITEM VOTE REQUIRED FOR APPROVAL EFFECT OF ABSTENTIONS (or the withholding of authority) EFFECT OF BROKER NON-VOTES 1 Election of six directors Plurality - the six director nominees who receive the most "FOR" votes will be elected to serve on the Board No effect No effect 2 Advisory approval of the compensation of OptimizeRx's named executive officers Number of votes cast in favor exceeds number of votes cast in opposition No effect No effect 3 Amendment to OptimizeRx Corporation 2021 Equity Incentive Plan to increase the aggregate number of shares of common stock available for awards by 1,950,000 shares to 4,450,000 shares Number of votes cast in favor exceeds number of votes cast in opposition No effect No effect 4 Ratification of the appointment of independent auditor Number of votes cast in favor exceeds number of votes cast in opposition No effect No broker non -votes ;”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Mariyamma Varghese Presti | Director | 2026-05-01 | A | 13,060 | $0 | $0 | Common | Form 4 ↗ |
| Stephen Silvestro | Chief Executive Officer | 2026-05-15 | D | 5,219 | 5 | 27,191 | Common | Form 4 ↗ |
| Theresa Greco | Chief Commercial Officer | 2026-05-15 | D | 879 | 5 | 4,580 | Common | Form 4 ↗ |
| Theresa Greco | Chief Commercial Officer | 2026-05-15 | D | 914 | 5 | 4,762 | Common | Form 4 ↗ |
| James Lang | Director | 2026-06-09 | A | 34,517 | 0 | 0 | Common | Form 4 ↗ |
| Catherine Klema | Director | 2026-06-09 | A | 34,517 | 0 | 0 | Common | Form 4 ↗ |
| Lynn O'Connor Vos | Director | 2026-06-09 | A | 34,517 | 0 | 0 | Common | Form 4 ↗ |
| Mariyamma Varghese Presti | Director | 2026-06-09 | A | 17,258 | 0 | 0 | Common | Form 4 ↗ |
| Gregory Wasson | Director | 2026-06-09 | A | 34,517 | 0 | 0 | Common | Form 4 ↗ |
| Patrick Spangler | Director | 2026-06-09 | A | 34,517 | 0 | 0 | Common | Form 4 ↗ |
| Marion Odence-Ford | Chief Legal & Admin Officer | 2026-08-20 | A | 57,600 | 0 | 0 | Common | Form 4 ↗ |
| Brendan W. Merrell | Chief Operating Officer | 2026-08-20 | A | 57,600 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Silvestro | Chief Executive Officer | 2026-08-20 | A | 79,200 | 0 | 0 | Common | Form 4 ↗ |
| Andrew J. D'Silva | Chief Business Officer | 2026-08-20 | A | 57,600 | 0 | 0 | Common | Form 4 ↗ |
| Andrew J. D'Silva | Chief Business Officer | 2026-08-21 | D | 1,243 | 8 | 9,584 | Common | Form 4 ↗ |
| Edward Stelmakh | Chief Finance & Strat Officer | 2026-08-21 | D | 1,381 | 8 | 10,648 | Common | Form 4 ↗ |
| Stephen Silvestro | Chief Executive Officer | 2026-08-21 | D | 1,737 | 8 | 13,392 | Common | Form 4 ↗ |
| Brendan W. Merrell | Chief Operating Officer | 2026-08-21 | D | 1,020 | 8 | 7,864 | Common | Form 4 ↗ |
| Marion Odence-Ford | Chief Legal & Admin Officer | 2026-08-21 | D | 1,529 | 8 | 11,789 | Common | Form 4 ↗ |
| Andrew J. D'Silva | Chief Business Officer | 2026-09-01 | D | 1,432 | 8 | 11,256 | Common | Form 4 ↗ |
| Andrew J. D'Silva | Chief Business Officer | 2026-10-01 | D | 414 | 8 | 3,473 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (51 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Stephen Silvestro. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 2,717,717. View filing ↗
- Section 01, Theresa Greco. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 1,544,265. View filing ↗
- Section 01, Edward Stelmakh. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 1,524,170. View filing ↗
- Section 03, Reserve Proposal OTHER. DEF 14A, filed 2026-04-30. Section “ADVISORY VOTE ON EXECUTIVE COMPENSATION &” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-30. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Lynn O'Connor Vos. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 268,993.6. View filing ↗
- Section 08, Patrick Spangler. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 234,993.6. View filing ↗
- Section 08, Catherine Klema. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 227,993.6. View filing ↗
- Section 08, James Lang. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 203,993.6. View filing ↗
- Section 08, Gregory Wasson. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 200,993.6. View filing ↗
- Section 08, Stephen Silvestro. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Mariyamma Varghese Presti. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: —. View filing ↗
- Section 02, Mariyamma Varghese Presti 2026-05-01. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Silvestro 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theresa Greco 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theresa Greco 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James Lang 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Catherine Klema 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lynn O'Connor Vos 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mariyamma Varghese Presti 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gregory Wasson 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Spangler 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marion Odence-Ford 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brendan W. Merrell 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Silvestro 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew J. D'Silva 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew J. D'Silva 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward Stelmakh 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Silvestro 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brendan W. Merrell 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marion Odence-Ford 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew J. D'Silva 2026-09-01. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew J. D'Silva 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-12. Item 5.07 · say-on-pay result. As reported: 92.87% (votes for as printed: 11,660,549). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-16. Item 5.07 · say-on-pay result. As reported: 58.53% (votes for as printed: 5,443,720). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-07. Item 5.07 · say-on-pay result. As reported: 65.27% (votes for as printed: 8,790,190). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 387,000 + equity 749,968 + all other 0 = 1,136,968, summed across the director compensation table rows.
- Viant Technology Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Viant Technology Inc.'s own proxy. As printed: 9,634,679. View filing ↗
- Domo, Inc., Section 10b CEO total. DEF 14A, filed 2026-06-01. CEO total compensation as printed in Domo, Inc.'s own proxy. As printed: 9,465,244. View filing ↗
- Phreesia, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-14. CEO total compensation as printed in Phreesia, Inc.'s own proxy. As printed: 8,077,706. View filing ↗
- Kaltura, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Kaltura, Inc.'s own proxy. As printed: 6,412,754. View filing ↗
- SoundThinking, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in SoundThinking, Inc.'s own proxy. As printed: 4,600,051. View filing ↗
- American Well Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in American Well Corporation's own proxy. As printed: 4,162,171. View filing ↗
- Health Catalyst, Inc., Section 10b CEO total. DEF 14A, filed 2026-06-03. CEO total compensation as printed in Health Catalyst, Inc.'s own proxy. As printed: 3,991,159. View filing ↗
- OptimizeRx (subject), Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in OptimizeRx's own proxy. As printed: 2,717,717. View filing ↗
- Augmedix, Inc., Section 10b CEO total. DEF 14A, filed 2023-06-26. CEO total compensation as printed in Augmedix, Inc.'s own proxy. As printed: 1,157,484. View filing ↗
- Simulations Plus, Inc., Section 10b CEO total. DEF 14A, filed 2025-12-29. CEO total compensation as printed in Simulations Plus, Inc.'s own proxy. As printed: 1,096,572. View filing ↗
- CoreCard Corporation, Section 10b CEO total. DEF 14A, filed 2025-04-14. CEO total compensation as printed in CoreCard Corporation's own proxy. As printed: 906,669. View filing ↗
- HealthStream, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in HealthStream, Inc.'s own proxy. As printed: 868,037. View filing ↗
- iCAD, Inc., Section 10b CEO total. DEF 14A, filed 2024-04-29. CEO total compensation as printed in iCAD, Inc.'s own proxy. As printed: 849,047. View filing ↗